These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28802229)

  • 1. TGF-β-mediated repression of MST1 by DNMT1 promotes glioma malignancy.
    Guo Z; Li G; Bian E; Ma CC; Wan J; Zhao B
    Biomed Pharmacother; 2017 Oct; 94():774-780. PubMed ID: 28802229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation.
    Hua CD; Bian EB; Chen EF; Yang ZH; Tang F; Wang HL; Zhao B
    Biomed Pharmacother; 2018 Oct; 106():678-685. PubMed ID: 29990858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β-induced miR10a/b expression promotes human glioma cell migration by targeting PTEN.
    Liu S; Sun J; Lan Q
    Mol Med Rep; 2013 Dec; 8(6):1741-6. PubMed ID: 24100613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of human glioma cell growth, migration and invasion in vitro by transforming growth factor beta 1.
    Merzak A; McCrea S; Koocheckpour S; Pilkington GJ
    Br J Cancer; 1994 Aug; 70(2):199-203. PubMed ID: 8054266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway.
    Tang F; Wang H; Chen E; Bian E; Xu Y; Ji X; Yang Z; Hua X; Zhang Y; Zhao B
    J Cell Physiol; 2019 Dec; 234(12):23302-23314. PubMed ID: 31140621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
    Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
    Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezrin-dependent promotion of glioma cell clonogenicity, motility, and invasion mediated by BCL-2 and transforming growth factor-beta2.
    Wick W; Grimmel C; Wild-Bode C; Platten M; Arpin M; Weller M
    J Neurosci; 2001 May; 21(10):3360-8. PubMed ID: 11331365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of transforming growth factor-β inhibitor on the proliferation of glioma stem/progenitor cell.
    Zhang Q; Guo W; Di C; Lou M; Li H; Zhao Y
    Pol J Pathol; 2017; 68(4):312-317. PubMed ID: 29517201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
    Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
    J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
    Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic silencing of telomerase and a non-alkylating agent as a novel therapeutic approach for glioma.
    Patel R; Shervington L; Lea R; Shervington A
    Brain Res; 2008 Jan; 1188():173-81. PubMed ID: 18021753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nobiletin inhibits invasion via inhibiting AKT/GSK3β/β-catenin signaling pathway in Slug-expressing glioma cells.
    Zhang X; Zheng K; Li C; Zhao Y; Li H; Liu X; Long Y; Yao J
    Oncol Rep; 2017 May; 37(5):2847-2856. PubMed ID: 28339056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of B cell CLL/Lymphoma 11B Gene Expression Represses Glioma Cell Growth.
    Liao CK; Fang KM; Chai K; Wu CH; Ho CH; Yang CS; Tzeng SF
    Mol Neurobiol; 2016 Aug; 53(6):3528-3539. PubMed ID: 26096706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
    Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
    Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
    Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
    Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β promotes glioma cell growth via activating Nodal expression through Smad and ERK1/2 pathways.
    Sun J; Liu SZ; Lin Y; Cao XP; Liu JM
    Biochem Biophys Res Commun; 2014 Jan; 443(3):1066-72. PubMed ID: 24370825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells.
    Feng R; Dong L
    Int J Clin Exp Pathol; 2015; 8(6):6107-16. PubMed ID: 26261488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinol dehydrogenase 10 promotes metastasis of glioma cells via the transforming growth factor-β/SMAD signaling pathway.
    Guan F; Kang Z; Wang L; Wang K; Mao BB; Peng WC; Zhang BL; Lin ZY; Zhang JT; Hu ZQ
    Chin Med J (Engl); 2019 Oct; 132(20):2430-2437. PubMed ID: 31613821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma.
    Dong X; Deng Q; Nie X; Zhang M; Jia W; Chen C; Xu C; Xu R
    Exp Mol Pathol; 2015 Apr; 98(2):192-9. PubMed ID: 25617528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.